Presenters: Natasha Boghosian and Dr Katie Campbell
Watch this engaging webinar to learn about the impact of material science on the success of cell therapy manufacturing. This presentation provides several examples on how proper material selection and product design can play a major role in the optimization and overall success of numerous cell therapy process steps.
This webinar provides insight into:
- How cell therapy manufacturing processes can be impacted by material selection
- The critical aspects that go into creating a system, including material, process, and design considerations
- Case studies exploring different solutions that have required material property considerations, including, but not limited to: gas permeability, chemical resistance and sterilization stability
Simply fill in the form below to access the webinar recording:
Natasha (Lundgren) Boghosian
Product Manager, Cell Therapy, Saint-Gobain, USA
Natasha Boghosian is the Product Manager for Cell Therapy within Saint-Gobain's Bioprocessing Solutions business unit. Natasha joined Saint-Gobain in 2012 and previously served as a Process Development Engineer within the CertainTeed division and a Research Engineer within the Performance Plastics division. Natasha received her B.S. in Chemical Engineering from the Pennsylvania State University where she supplemented her studies through research internships in bioengineering and immunology.
Dr Katie Campbell
Senior Research Engineer, Saint-Gobain, USA
Katie Campbell is a Senior Research Engineer for Saint-Gobain Performance Plastics. Katie has a B.S. in Biomedical Engineering from Virginia Commonwealth University and a Ph.D. in Materials Science and Engineering from Georgia Tech. Katie joined DuPont in their Teflon® business upon completion of a short post-doc where she researched new Teflon® fluoropolymer chemistries. Katie joined Saint-Gobain in 2015 as part of the R&D team located in Northborough, MA and is focused on Cell Therapy product development.